Frederick Jones
Nephrology · Raleigh, NCNPI 1023044013
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 24.7% of the total.
Across 143 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$725
- Otsuka America Pharmaceutical, Inc.$546
- Fresenius USA Marketing, Inc.$296
- Amgen$261
- Akebia Therapeutics Inc$164
- OPKO Pharmaceuticals, LLC$140
- plus $802 from 16 others
What the payments were for
- Food & beverage$2,88498%
- Education$512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 31 | $725 |
| Otsuka America Pharmaceutical, Inc. | 26 | $546 |
| Fresenius USA Marketing, Inc. | 17 | $296 |
| Amgen(2 entities) | 16 | $261 |
| Akebia Therapeutics Inc | 10 | $164 |
| OPKO Pharmaceuticals, LLC | 9 | $140 |
| Amicus Therapeutics, Inc. | 1 | $122 |
| Vifor Pharma, Inc. | 6 | $120 |
| Aurinia Pharma U.S., Inc. | 5 | $90 |
| Bayer | 4 | $70 |
| Mallinckrodt Hospital Products Inc. | 3 | $67 |
| Calliditas Therapeutics US Inc. | 2 | $51 |
| Sanofi | 2 | $47 |
| Travere Therapeutics, Inc. | 2 | $46 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $43 |
| Mallinckrodt Enterprises LLC | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| GSK | 1 | $18 |
| Shire North American Group Inc | 1 | $14 |
| Nuwellis, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,934 in reported general payments places this provider in the 65th percentile of 366 nephrology providers in North Carolina.
Other nephrology in Raleigh
- Sammy MoghaziRaleigh$56K
- Jeffrey HoggardRaleigh$48K
- Libbie McKenzieRaleigh$34K
- Karn GuptaRaleigh$10K
- Michael CaseyRaleigh$7K
- Phillip TimmonsRaleigh$6K
- Gregory GreenwoodWinston-Salem$947K
- Michael EtomiCharlotte$212K
- William KendrickGreenville$125K
- Jason EckelCary$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.